By targeting both GLP-1 and GIP pathways, this therapy addresses appetite, insulin response, and fat utilization more comprehensively than single-pathway options a key reason providers recommend it for patients needing stronger results
Starting at lower dose ranges and titrating based on tolerability and response represents a conservative approach consistent with general peptide therapy principles
13 No conclusions can be drawn
Inside the DSC Practitioner Membership , youll get access to 350+ editable client handouts , including our brand-new GLP-1 Nutrition handout
Gastroenterology 113 , 16821691 (1997)
While this test doesn't address storage, understanding your genetic peptide pathway helps PlexusDx personalize your dose and medication selection, maximizing results when storage is properly maintained